Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SWISSPED-RECOVERY in Children With PIMS-TS
NCT04826588Phase 3Completed
- Sponsor
- University Children's Hospital Basel
- Start
- May 2021
- Primary completion
- Nov 2022
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of methylprednisolone injection, Intravenous Human Immunoglobulin (pH4) (Wuhan Zhong Yuan Rui De) in Paediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2 (MIS-C), sponsored by University Children's Hospital Basel. Started May 2021; status: completed.
02
Drugs
methylprednisolone injectionIntravenous Human Immunoglobulin (pH4) (Wuhan Zhong Yuan Rui De)
03
Conditions
Paediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2 (MIS-C)
Beyond the preview
Go deeper on NCT04826588.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04826588.